none4noneSerretti A.; Benedetti F.; Zanardi R.; Smeraldi E.Serretti A.; Benedetti F.; Zanardi R.; Smeraldi E
Objective Gene variants within the serotonin pathway have been associated with major depressive diso...
Objective: Previous evidence suggested the involvement of serotonin transporter (SLC6A4) and activit...
Objective:Several studies have implicated the 5-HTTLPR polymorphism in treatment outcomes of selecti...
none3noIn the last decade the serotonin transporter gene promoter polymorphism (5-HTTLPR) was likely...
of psychiatry, university of bologna, bologna, italy SummARy – depression pharmacotherapy can be des...
Background: The serotonin transporter gene-linked polymorphic region (5-HTTLPR) has been proposed as...
The majority of antidepressant drugs act by increasing synaptic serotonin levels in the brain. Genet...
Background and Objectives. Several gene variants have been related to major depressive disorder (MDD...
none17siOBJECTIVE: Gene variants within the serotonin pathway have been associated with major depres...
BACKGROUND: In major depressive disorder, selective serotonin reuptake inhibitors target the seroton...
Antidepressants are used to treat several psychiatric disorders; however, a large proportion of pati...
Background Antidepressants exhibit a variety of pharmacological actions including inhibition of t...
Selective serotonin and serotonin-norepinephrine reuptake inhibitors (SSRI/SNRI) are commonly used f...
BACKGROUND: Antidepressants exhibit a variety of pharmacological actions including inhibition of the...
Individuals with the short (S) allele in the promoter region of the serotonin transporter gene (5-HT...
Objective Gene variants within the serotonin pathway have been associated with major depressive diso...
Objective: Previous evidence suggested the involvement of serotonin transporter (SLC6A4) and activit...
Objective:Several studies have implicated the 5-HTTLPR polymorphism in treatment outcomes of selecti...
none3noIn the last decade the serotonin transporter gene promoter polymorphism (5-HTTLPR) was likely...
of psychiatry, university of bologna, bologna, italy SummARy – depression pharmacotherapy can be des...
Background: The serotonin transporter gene-linked polymorphic region (5-HTTLPR) has been proposed as...
The majority of antidepressant drugs act by increasing synaptic serotonin levels in the brain. Genet...
Background and Objectives. Several gene variants have been related to major depressive disorder (MDD...
none17siOBJECTIVE: Gene variants within the serotonin pathway have been associated with major depres...
BACKGROUND: In major depressive disorder, selective serotonin reuptake inhibitors target the seroton...
Antidepressants are used to treat several psychiatric disorders; however, a large proportion of pati...
Background Antidepressants exhibit a variety of pharmacological actions including inhibition of t...
Selective serotonin and serotonin-norepinephrine reuptake inhibitors (SSRI/SNRI) are commonly used f...
BACKGROUND: Antidepressants exhibit a variety of pharmacological actions including inhibition of the...
Individuals with the short (S) allele in the promoter region of the serotonin transporter gene (5-HT...
Objective Gene variants within the serotonin pathway have been associated with major depressive diso...
Objective: Previous evidence suggested the involvement of serotonin transporter (SLC6A4) and activit...
Objective:Several studies have implicated the 5-HTTLPR polymorphism in treatment outcomes of selecti...
DOI
Add to ORKG